Daré Bioscience (DARE) Earnings Date, Estimates & Call Transcripts → RE: Your account status (From MarketBeat) (Ad) Free DARE Stock Alerts $0.41 -0.02 (-4.65%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 14) -$0.07 Missed By -$0.01 Consensus EPS (May. 14) -$0.06 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Daré Bioscience Earnings AlertsEnter your email address below to receive the latest news and earnings results for DARE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDARE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DARE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Daily Strike Alliance🚀 Tap into this explosive trade opportunity asapI learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. Daré Bioscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.07)($0.06)($0.07)Q2 20242($0.06)($0.05)($0.06)Q3 20242($0.07)($0.07)($0.07)Q4 20242($0.07)($0.04)($0.06)FY 20248($0.27)($0.22)($0.25)Q1 20251($0.02)($0.02)($0.02)Q2 20251$0.03$0.03$0.03Q3 20251$0.02$0.02$0.02Q4 20251$0.09$0.09$0.09FY 20254$0.12$0.12$0.12DARE Earnings Date and InformationDaré Bioscience last posted its earnings results on May 14th, 2024. The biotechnology company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by $0.01. The company earned $0.01 million during the quarter, compared to analysts' expectations of $0.52 million. Daré Bioscience has generated ($0.32) earnings per share over the last year (($0.32) diluted earnings per share). Earnings for Daré Bioscience are expected to grow in the coming year, from ($0.23) to $0.11 per share. Daré Bioscience has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Daré Bioscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/14/2024Q1 2024($0.06)($0.07)($0.01)($0.07)$0.52 million$0.01 million 3/28/2024Q4 2023($0.12)($0.06)+$0.06($0.06)$2.17 million$1.81 million11/9/2023Q3 2023($0.10)($0.09)+$0.01($0.09)$1.20 million$1.00 million8/10/2023Q2 2023($0.10)($0.10)-($0.10)--5/11/2023Q1 2023($0.10)($0.09)+$0.01($0.09)--3/30/2023Q4 2022($0.15)($0.19)($0.04)($0.19)-- Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.11)($0.08)+$0.03($0.08)--5/12/2022Q1 2022($0.14)($0.10)+$0.04($0.10)--3/31/2022Q4 2021($0.21)($0.18)+$0.03($0.18)-- 11/10/2021Q3 2021($0.13)($0.18)($0.05)($0.18)-- 8/11/2021Q2 2021($0.16)($0.18)($0.02)($0.18)-- 5/13/2021Q1 2021($0.23)($0.16)+$0.07($0.16)-- 3/29/2021Q4 2020($0.13)($0.28)($0.15)($0.22)-- 11/17/2020Q3 2020($0.17)($0.24)($0.07)($0.24)-- 8/12/2020Q2 2020($0.14)($0.27)($0.13)($0.27)-- 5/14/2020Q1 2020($0.34)($0.18)+$0.16($0.18)-- 3/30/2020Q4 2019($0.22)($0.21)+$0.01($0.21)-- 11/14/2019Q3 2019($0.21)($0.20)+$0.01($0.20)-- 8/14/2019Q2 2019($0.20)($0.29)($0.09)($0.29)-- Daré Bioscience Earnings - Frequently Asked Questions When is Daré Bioscience's earnings date? Daré Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on DARE's earnings history. Did Daré Bioscience beat their earnings estimates last quarter? In the previous quarter, Daré Bioscience (NASDAQ:DARE) missed the analysts' consensus estimate of ($0.06) by $0.01 with a reported earnings per share (EPS) of ($0.07). Learn more on analysts' earnings estimate vs. DARE's actual earnings. How can I listen to Daré Bioscience's earnings conference call? The conference call for Daré Bioscience's latest earnings report can be listened to online. Listen to Conference Call How can I read Daré Bioscience's conference call transcript? The conference call transcript for Daré Bioscience's latest earnings report can be read online. Read Transcript How can I view Daré Bioscience's earnings report? Daré Bioscience's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Daré Bioscience generate each year? Daré Bioscience (NASDAQ:DARE) has a recorded annual revenue of $2.81 million. How much profit does Daré Bioscience generate each year? Daré Bioscience (NASDAQ:DARE) has a recorded net income of -$30.16 million. DARE has generated -$0.32 earnings per share over the last four quarters. What is Daré Bioscience's EPS forecast for next year? Daré Bioscience's earnings are expected to grow from ($0.23) per share to $0.11 per share in the next year. More Earnings Resources from MarketBeat Related Companies: HCWB Earnings Results ACXP Earnings Results CASI Earnings Results NRXP Earnings Results CARA Earnings Results OCUP Earnings Results GANX Earnings Results AADI Earnings Results IMRX Earnings Results DRRX Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:DARE) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWho are Nvidia’s New Silent Partners?Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry ResearchGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.